Meridian Medical Technologies, Inc.

Meridian Medical Technologies, Inc., a subsidiary of King Pharmaceuticals, Inc., has been manufacturing auto-injectors for emergency drug delivery for more than 50 years and has provided more than 185 million auto-injectors to the world market. Meridian's products include: the DuoDote Auto-Injector the latest advancement in chemical nerve agent antidote technology a single, pre-filled, dual-chambered auto-injector containing atropine and pralidoxime chloride; the AtroPen Auto-Injector (atropine injection); the Pralidoxime Chloride Auto-Injector (pralidoxime chloride injection); the Diazepam Auto-Injector (diazepam injection); and the Morphine Auto-Injector (morphine injection).